Literature DB >> 7056025

Quantitation of biliary excretion of drugs in man.

C A Dujovne, J H Gustafson, R A Dickey.   

Abstract

An experimental model was developed to allow extended investigation (up to3 days) of the kinetics of upper gastrointestinal elimination (including enterohepatic recirculation) of drugs or metabolites in normal subjects under near physiologic conditions. The test drug (100 mg carprofen) was given by mouth or through a triple-lumen nasogastric tube to the upper duodenum to three normal subjects. The amounts of drug and metabolite passing the gastrointestinal aspiration port for each time interval were calculated from the concentrations measured in the aspirate using dual nonabsorbable markers and continuous sampling and reinfusion of intestinal fluids. Crossover studies without intubation in the same subjects and comparisons to historical controls demonstrated that the intubation procedure did not affect normal kinetic data obtained from conventional blood and urine specimens. The model permits direct comparison of gastrointestinal-biliary clearance with renal and with total body clearance and is particularly useful in resolving kinetic questions of gastrointestinal-biliary excretion or recirculation of metabolites when a drug must be taken by mouth. Potential first-pass phenomena may also be investigated by means of incremental gastrointestinal clearance values.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7056025     DOI: 10.1038/clpt.1982.30

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  3 in total

1.  Quantitative measurement of biliary excretion and of gall bladder concentration of drugs under physiological conditions in man.

Authors:  A Lanzini; M G Pigozzi; A Wuhrer; D Facchinetti; M Castellano; L Bettini; U P Guerra; M Beschi; G Muiesan
Journal:  Gut       Date:  1989-01       Impact factor: 23.059

2.  Use of Entero-Test, a simple approach for non-invasive clinical evaluation of the biliary disposition of drugs.

Authors:  William J Guiney; Claire Beaumont; Steve R Thomas; Darren C Robertson; Simon M McHugh; Annelize Koch; Duncan Richards
Journal:  Br J Clin Pharmacol       Date:  2011-07       Impact factor: 4.335

3.  The influence of cholestyramine on the elimination of tenoxicam and piroxicam.

Authors:  T W Guentert; R Defoin; H Mosberg
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.